We are a nutritional and pharmaceutical development company focused on the licensing, development and commercialization of safe and effective treatments for cats and dogs based on cutting edge human cancer technologies.
Animal Life Sciences was founded by leading scientists, clinicians and executives with decades of experience in drug discovery and bringing products to the market.
Our Strategy
Our strategy is to leverage the breakthrough advances in human drug development generated from leading cancer research institutions, by applying them to veterinary medicine under the guidance of our leading experts.
Our goals
We plan to continue to expand our development pipeline by licensing more drug technologies and to utilize our scientific and clinical expertise to create a brand of scientifically engineered food products for direct distribution to pet owners across the globe.
IF YOU DIDN'T KNOW...
Cancer is the
leading cause
of death among
dogs and cats.
Almost 50% of dogs and 33% of cats over the age of 10 will die of cancer.
Billions in research dollars have been spent to improve our own health. It’s time we used some of that know-how for our best friends.
Our consumer based pet food line is being scientifically engineered, patented and formulated at MD Anderson, the world's LARGEST and most respected center.
Our pet food is
launching soon!
WHY WE'RE HERE
Bridging the
innovation gap.
Progress in veterinary medicine lags years behind the scientific breakthroughs seen in human health.
This innovation gap between human science and veterinary medicine was the primary reason Animal Life Sciences was founded.
See our supplements being formulated at MD Anderson.
The world's largest and most respected center devoted exclusively to cancer patient care, research, education and prevention.
Texas A&M College of Veterinary Medicine & Biomedical Sciences
The Texas A&M University College of Veterinary Medicine & Biomedical Sciences is a major veterinary educational, medical and research institution located in Texas.
Wake Forest University
Wake Forest Health Sciences strategically investigates opportunities that will expand basic and clinical research, resulting in nationally and internationally recognized excellence in biomedical research.
Moleculin Biotech
Moleculin is a Nasdaq listed clinical stage pharmaceutical company focused on the development of oncology drug candidates, some of which are based on discoveries made at MD Anderson Cancer Center.
Use left/right arrows to navigate the slideshow or swipe left/right if using a mobile device
choosing a selection results in a full page refresh
press the space key then arrow keys to make a selection